These and other data have been taken to suggest that high canonical WNT signaling in different human cancers, including those of the colon, is essential for tumor growth and metastases in patients, arguing for the development of therapeutic WNT-TCF pathway antagonists (e.g. [3]). This evidence concerns the gene HNF4A and neoplasm.